Dow Global Technolgoies LLC

Neosync, Inc.

Wave Neuroscience, Inc.

Kosivana Holdings Limited

Newport Brain Research Laboratory Inc.

Yi Jin

James William Phillips

Selim Yalvac

Allan Walter Mclennaghan

Kim Louis Walton

Gary Robert Marchand

Rongjuan Cong

Morgan Mark Hughes

Shrikant Dhodapkar

Timothy Wayne Gambrel

Mehmet Demirors

Rajen M Patel

Mohamed Esseghir

Selim Bensason

Theresa J Hermel-Davidock

Santosh S Bawiskar

Jose Eduardo Ruiz

Jeffrey D Weinhold

Jozef Van Dun

Cynthia L Rickey

Carl N Iverson

Ronald J Weeks

Yichi Zhang

Jerzy Klosin

Edmund M Carnahan

Colin Li Pi Shan

Philip P Fontaine

Ronald Wevers

Debkumar Bhattacharjee

Chester J Kmiec

Yushan Hu

Kate R Brown

Frank J Cerk

Sarah M Hayne

Gregory M Bunker

Prashant Mandare

Xuming Chen

Michael Joseph Zogg, Jr

Wanfu Ma

Ling Zhang-Watson

Dean Lee

Colin LiPiShan

Brad C Bailey

Harold W Boone

Karl M Seven

Xiaodong Zhang

Thomas W Karjala

Guang Ming Li

Lamy J Chopin, Iii

Jozef J I Van Dun

Randy E Pepper

Harold Christian Fowler

Olaf Henschke

Sylvie Vervoort

David J Magley

Charles Knezevich

Robert D Silvetz

Burcak Conley

Daniel S Rynearson

Bindushree Radhakrishnan

Erdem Bedri

Lonnie Schilhab

Stacy L Pesek

Ryan Schneider

Mark Chien

A Willem Degroot

Barry D Kluge, Jr

Jozef J Van Dun

Lamy J Chopin Iii

Jr Michael J Zogg

Jozef JI Van Dun

Michael J Zogg Jr

Jr Barry D Kluge

Allan W Mclennaghan

Hermann Hentz

Described are methods and a device for determining a valid intrinsic alpha frequency. Described herein are methods and a device for determining the appropriate intrinsic alpha frequency (IAF) to be applied for neuro-EEG synchronization therapy using alternating magnetic fields to gently 'tune' the brain and affect the mood, focus and cognition of subjects. Methods and a device described herein use an algorithm to quantitatively analyze EEG recordings to determine if recorded EEG frequencies are valid, and if necessary, requiring additional recordings and analysis until a valid EEG is found. Methods and devices described herein can be utilized to calculate the intrinsic frequency of other EEG bands, including the Theta, Beta Gamma and Delta bands.

Method and device for determining a valid intrinsic frequency

The present disclosure provides a composition. The composition contains (A) an ethylene/α-olefin copolymer containing (i) ethylene and (ii) from 20 wt % to 35 wt % C-Cα-olefin comonomer, the ethylene/α-olefin copolymer having a density from 0.880 g/cc to 0.895 g/cc, a melt viscosity, at 177° C., from 4,000 mPa·s to 20,000 mPa·s, and a glass transition temperature from −55° C. to −20° C.; (B) a tackifier, and (C) a wax.

Adhesive composition

A composition comprising the following components: A) propylene/ethylene copolymer that has a density ≤0.880 g/cc, and a MWD(conv) from 2.00 to 3.00 and a melt viscosity (177 C)≤80,000 mPa*s; B) olefin multi-block copolymer that has a density ≤0.890 g/cc and a melt index (I2)≥0.5 g/10 min.

Compositions containing low molecular weight propylene-based polymers and an olefin multi-block copolymer

An apparatus to batch or continuously form solid polymer particles, the apparatus comprising the following components: A) at least one pastillation unit comprising a pastillation head, said unit used to form discrete molten polymer particles from a polymer melt; B) a moving belt to receive and transfer the discrete molten polymer particles from the pastillation head; C) a means to transfer water onto the moving belt, such that the water comes into contact with the discrete molten polymer particles on the moving belt to form the solid polymer particles; and wherein the water of component C is sprayed onto the discrete molten polymer particles, such that the ratio of 'the rate of water spray' to “the discharge rate” is ≥3.0; and wherein the belt residence time is ≤50 seconds.

Apparatus and method for granulating low viscosity materials

Described are novel systems for the diagnosis of specific mental disorders using neurometrics. EEG parameters are compared to thresholds to determine if a person is suffering from autism spectrum disorder, Alzheimer's disease, anxiety, depression, or schizophrenia.

System for diagnosing mental disorders using neurometrics

Described are methods, devices, and systems for a novel, inexpensive, easy to use therapy for a number of disorders. Described are methods and devices to treat disorders that involves no medication. Methods and devices described herein use alternating magnetic fields to gently 'tune' the brain and affect mood, focus, and cognition of subjects.

Systems for neuro-EEG synchronization therapy

Described are methods, devices, and systems for a novel, inexpensive, easy to use therapy for treatment of anxiety. Described are methods and devices to treat anxiety that involves no medication. Methods and devices described herein use alternating magnetic fields to gently 'tune' the brain and affect symptoms of anxiety.

Methods for treating anxiety using neuro-EEG synchronization therapy

High frequency repetitive magnetic pulses may be used to treat pain in the foot of a person by relaxing the muscle and reducing communication of pain signals by neurons in the treatment region. A device is disclosed, which is floor mounted and incorporates a cooling mechanism and heat sink to allow high frequency magnetic stimulation to the person's foot.

High frequency magnetic foot stimulation

A composition is provided, which comprises an ethylene/C3-C6 alpha-olefin interpolymer, and wherein the interpolymer comprises the following properties:

Ethylene/C3-C6 alpha-olefin interpolymers with improved pellet flowability

A composition comprising an acid and/or anhydride grafted ethylene/alpha-olefin interpolymer that comprises the following properties: A) number of grafts per polymer chain&#x2265;1.80, and B) melt viscosity (at 177&#xb0; C.)&#x2264;50,000 mPa&#xb7;s.

Functionalized ethylene/alpha-olefin interpolymers with high graft levels

Described are methods, devices, and systems for a novel, easy to use treatment for spasticity that does not involve medication. Methods and devices herein use low-frequency repetitive magnetic fields to enhance communication in the spinal nerve, thereby allowing improved relaxation, control, and coordination in a muscle.

Systems and methods for spasticity treatment using spinal nerve magnetic stimulation

Systems and methods for anxiety treatment using neuro-EEG synchronization therapy

The invention provides compositions, each comprising an ethylene/alpha-olefin interpolymer, which has a reduced level of a low density, low molecular weight oligomeric fraction, as indicated by an HCC value, as described herein, and reduced levels of inorganic content or lower Tm. The invention also provides processes for forming such interpolymers.

Ethylene/alpha-olefin interpolymers with improved pellet flowability

A process to form an olefin-based polymer, said process comprising at least the following steps: a) polymerizing a reaction mixture comprising an olefin, in at least one reactor, in a solution polymerization, to form a polymer solution; b) feeding at least a portion of the polymer solution through at least one devolatilizer, to form the olefin-based polymer, in melt form; c) feeding at least a portion of the olefin-based polymer, in melt, form through a heat exchanger, and then into a pastillation apparatus to form polymer particles.

Polymerization and isolation of low viscosity polymers using pastillation technology

The present disclosure provides a composition. In an embodiment an adhesive composition is provided and includes (A) a propylene-based interpolymer having a density from 0.850 g/cc to 0.900 g/cc; (B) an ethylene-based polymer composition having a melt viscosity at 140&#xb0; C. from 10 mPa*s to 1,000 mPa*s; and (C) a tackifier. The composition has a molecular weight distribution ratio from 1.00 to 1.40, wherein the molecular weight distribution ratio is the molecular weight distribution of the propylene-based interpolymer of component (A) compared to the molecular weight distribution of the ethylene-based polymer composition of component (B). The composition has a density ratio from 0.93 to 1.30, wherein the density ratio is the density of the propylene-based interpolymer of component (A) compared to the density of the ethylene-based polymer composition of component (B).

Growing community of inventors

Irvine, CA, United States of America

Yi Jin